Please ensure Javascript is enabled for purposes of website accessibility

Insys bankruptcy could complicate some Md. opioid cases (access required)

Insys Therapeutics' decision to declare bankruptcy last week won't halt Maryland's administrative charges against the opioid manufacturer but could affect lawsuits by cities and counties currently pending in state and federal court. Insys, which manufactures the opioid spray Subsys, filed for Chapter 11 protection on June 10 after agreeing to pay $225 million to resolve a ...

To purchase a reprint of this article, contact [email protected].